December 15, 2017 / 9:04 PM / 2 months ago

BRIEF-Repros Says Received EMA Feedback That Negative Opinion Is Likely To Be Received In Jan 2018

Dec 15 (Reuters) - Repros Therapeutics Inc:

* REPROS THERAPEUTICS INC.® RECEIVES FEEDBACK FOLLOWING AN ORAL EXPLANATION WITH THE EUROPEAN MEDICINES AGENCY

* REPROS THERAPEUTICS - FOLLOWING ORAL EXPLANATION, HAS RECEIVED FEEDBACK THAT A NEGATIVE OPINION IS LIKELY TO BE RECEIVED IN JANUARY 2018 FROM CHMP

* REPROS THERAPEUTICS INC - OPINION IS LIKELY TO BE RECEIVED FROM CHMP FOR CENTRALIZED MAA FOR ENCLOMIPHENE FOR TREATMENT OF SECONDARY HYPOGONADISM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below